Strongbridge Biopharma Announces Acquisition of the U.S. and Canadian Rights to MACRILENâ„¢ (macimorelin) from Aeterna Zentaris
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026